Effects of alfalfa on lipoproteins and fatty streak formation in hypercholesterolemic rabbits

Pakistan Journal of Pharmaceutical Sciences

Volumn 21, Issue 4, 2008, Pages 460-464

  Asgary, S ^a   Moshtaghian, J ^b   Hosseini, M ^b   Siadat, H ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

Alfalfa; Atherosclerosis; Phytoestrogen; Rabbit

Indexed keywords

ANTILIPEMIC AGENT; LIPOPROTEIN; PLANT MEDICINAL PRODUCT;

ALFALFA; ANIMAL; ARTICLE; ATHEROSCLEROSIS; DIET; DISEASE MODEL; HYPERCHOLESTEROLEMIA; MALE; METABOLISM; PATHOLOGY; PHYTOTHERAPY; PLANT; RABBIT;

ANIMALS; ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; DIET; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; MALE; MEDICAGO SATIVA; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT PREPARATIONS; RABBITS;

EID: 58149261929     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adlercreutz H (1998). Epidemiology of phytoestrogens. Baillieres Clin. Endocrinol. Metab., 12: 605-623.
2. Aldercreatz H, Markkanen H and Watanabe S (1993). Plasma concentrations of phytoestrogens in Japanese men. Lancet, 342: 1209-1210.
3. Axelson M, Sjovall J, Gustafsson BE and Stechell KD (1984). Soya a dietary source of the nonsteroidal oestrogen equal in man and animals. Endocrinol, 102: 49-56.
4. Barens DK and Sheaffer C (1995) Alfalfa. Agri, 2: 205-216.
5. Clermont PJ, Creager M, Lorsordo WL, Lam G, Wassef M and Dzau V (2005). Atherosclerosis: recent discoveries and novel hypotheses. Circulation, 112: 3343-3353.
6. Colodny LR, Montgomery A and Houston M (2001). Alfalfa saponins may help reduce cholesterol levels. Journal of the American Nutraceutical Association, 3: 1-10.
7. Elakovich SD and Hampton JM (1988). Analysis of Coumestrol, phytoestrogens, in alfalfa tablets sold for human consumption. J. Agri. Food Chem., 32: 173-175.
8. Figtree GA, Griffiths BH, Ying-Qing LU, Web CM, Macleod K and Collins P (2000). Plant-Derived estrogens relax coronary arteries in vitro by a calcium antagonist mechanism. J. Am. Cardiol., 35: 7.
9. Fisher BA, Mortenseb JF, Hansen P and Ibsen H (1994). Atherosclerosis in watanabe heritable hyperlipidemic rabbits. Evaluation by microscopic and biochemical methods and comparison of atherosclerosis variables. APMIS., 102: 177-190.
10. Helena J, Barry P, Lakmini D and Paul JN (2003). Isoflavones reduce arterial stiffness, a placebo controlled study in men and postmenopausal women. Atheroscer Throm Vasc Biol., 78: 1966-1071.
11. Hertog MG, Kromhont D and Aravanis C (1995). Flavonoid intake and long- term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med., 155: 381-386.
12. Honore EK, Williams JK, Anthony MS and Clarkson TB (1997). Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril., 67: 148-154.
13. Jayapal V, Albertazzi P and Howarth E (2002). Beneficial effects of soy phytostrogen intake in postmenopausal women with type 2 diabetes. Diabet., 25: 1702-1714.
14. Molgard J, Vonschnck H and Olsson A (1987). Alfalfa seeds lower low-density lipoprotein cholesterol and apolipoprotein B concentration: patients with type 2 hyperlipoprpteiemia. Atheroscler., 65: 173-179.
15. Moravcova J and Kleinova J (2001). The determination of isoflavones and coumestrol by capillary electrophorsis. Czech. J. Food Sci., 199: 132-138.
16. Naftolin F and Stanbury G (2002). Phytoestrogens: are they really estrogen mimics? Fertility. Sterility, 77: 15-18.
17. Nestel PJ, Pomeroy S and Kay S (1999). Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab., 88: 895-898.
18. Nogowski L, Nowak KW and Mack W (1999). Effects of phytoestrogen- coumestrol and estrogen on some aspects of carbohydrate metabolism in ovariectomized femal rats. Arch. Vet. Pol., 32: 79-84.
19. Nogowski L (1999). Effects of phytoestrogen-coumestrol on lipid and carbohydrate metabolism in young ovariectomized rats may be independent of its estrogenicity. J. Nutr. Biochm., 10: 664-669.
20. Sirtory CR, Gianazza E and Manzoni C (1984). Role of isoflavone in cholesterol reducation by soy protein in the clinic. Am. J. Clin. Nutr., 65: 166-710.
21. Skibola CF and Smith MT (2000). Potential health impacts of excessive flavonoid intake. Free Radical. Biol. Med., 29: 375-383.
22. Squadrito F, Altavilla D, Morabito N, Crisafulli A, Anna R, Corrado F (2002). The effect of the phtoestrogen genistein on plasma nitric oxide concentration, endothelian-1 levels and endothelium dependent vasodilation in postmenopausal women. Aheroscer., 163: 339-343.
23. Teede HI, Dalais F, Kotsopoulos D, Liang YL and Mcgrath BP (2001). Soy protein dietary supplementation containing phytoestrogens improves lipid profiles and blood pressure: a double blind, placebo controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab., 86: 3053-3060.
24. Whitten PL (2001). Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidant in the presence of acerola extracts. J. Agri. Chem., 49: 308-314.